{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:33:22Z","timestamp":1794666802780,"version":"4.9.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhltonline.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.healun.2024.08.019","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T21:41:34Z","timestamp":1725140494000},"page":"1998-2007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study"],"prefix":"10.1016","volume":"43","author":[{"given":"Raymond L.","family":"Benza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Gaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazzareno","family":"Gali\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius M.","family":"Hoeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallerie V.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1942-1951","authenticated-orcid":false,"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurinderpal","family":"Doad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7749-692X","authenticated-orcid":false,"given":"Xiaoqin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Tapson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.08.019_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: the REVEAL Risk Score Calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.08.019_bib2","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2024.08.019_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chest.2020.08.2069","article-title":"Development and validation of an abridged version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension","volume":"159","author":"Benza","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.healun.2024.08.019_bib4","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2024.08.019_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s12325-021-01898-1","article-title":"Long-term survival, safety and tolerability with selexipag in patients with pulmonary arterial hypertension: results from GRIPHON and its open-label extension","volume":"39","author":"Gali\u00e8","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.healun.2024.08.019_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2024.08.019_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.healun.2022.08.006","article-title":"Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension \u2013 an analysis of FREEDOM-EV","volume":"41","author":"Benza","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.019_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/a0031034","article-title":"Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros","volume":"18","author":"Valeri","year":"2013","journal-title":"Psychol Methods"},{"key":"10.1016\/j.healun.2024.08.019_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(23)00155-8","article-title":"Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trials","volume":"11","author":"Blette","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2024.08.019_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.healun.2019.12.013","article-title":"Risk assessment in pulmonary arterial hypertension: insights from the GRIPHON study","volume":"39","author":"Sitbon","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.019_bib11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.healun.2021.10.013","article-title":"Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study","volume":"41","author":"Benza","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.019_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/sim.4780110204","article-title":"Statistical validation of intermediate endpoints for chronic diseases","volume":"11","author":"Freedman","year":"1992","journal-title":"Stat Med"},{"key":"10.1016\/j.healun.2024.08.019_bib13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/CIRCULATIONAHA.114.009690","article-title":"Are hemodynamics surrogate end points in pulmonary arterial hypertension?","volume":"130","author":"Ventetuolo","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.08.019_bib14","doi-asserted-by":"crossref","first-page":"00456-2022","DOI":"10.1183\/23120541.00456-2022","article-title":"Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension","volume":"9","author":"Coghlan","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.healun.2024.08.019_bib15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2017.12.010","article-title":"Pulmonary arterial hypertension-related morbidity is prognostic for mortality","volume":"71","author":"McLaughlin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2024.08.019_bib16","doi-asserted-by":"crossref","unstructured":"Paoli CJ, Kime N, Williams K, et al. Modern treatment patterns in incident pulmonary arterial hypertension (PAH) patients: real-world data from the Pulmonary Hypertension Association (PHA) registry. Paper presented at: American Heart Association Annual Meeting. November 11-13, 2023;\u00a0Philadelphia, PA.","DOI":"10.1161\/circ.148.suppl_1.13633"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824018084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824018084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:22:25Z","timestamp":1731586945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824018084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1053249824018084"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.08.019","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}